Growth and Demand of Bioburden Testing in Biotechnology and Pharmaceutical Industry | Impact of COVID-19
The bioburden testing market is witnessing growth due to factors such as growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination are expected to drive the growth of this market during the forecast period. Bioburden Testing Market Dynamics: Impact Analysis 1. Geographical Snapshot of the Bioburden Testing Market 2. Growth Opportunities in Emerging Economies 3. Growth in the Medical Devices, Pharmaceutical, and Biotechnology Sector 4. Safety Concerns Related to Food and Beverage Products 5. Increasing Food Imports Into the US The bioburden testing market to grow from USD 1.10 billion by 2023 from USD 0.61 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 12.4% Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Bioburden Testing market? 2. What are the drivers, r...